Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (591-600 of 662) with videos related to

Pageof 67
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2016
Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic MastocytosisCelalettin Ustun, Jason Gotlib, Uday Popat, et al.
Hemasphere|December 2, 2024
Dual specific STAT3/5 degraders effectively block acute myeloid leukemia and natural killer/T cell lymphomaDaniel Pölöske, Helena Sorger, Anna Schönbichler, et al.
The Journal of Allergy and Clinical Immunology|March 22, 2021
Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator ConferenceJason Gotlib, Tracy I George, Melody C Carter, et al.
Cell Reports. Medicine|March 18, 2026
Polθ activity modulates sensitivity to standard therapies in DNMT3A-deficient leukemiaBac Viet Le, Umeshkumar Vekariya, Monika M Toma, et al.
Wiener Klinische Wochenschrift|November 27, 2012
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectivesPeter Valent, Michel Arock, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 31, 2024
Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNMPeter Valent, Karin Hartmann, Gregor Hoermann, et al.
Haematologica|May 4, 2019
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditionsPeter Valent, Attilio Orazi, Michael R Savona, et al.
The Journal of Investigative Dermatology|February 13, 2021
Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on MastocytosisElisabeth Aberer, Wolfgang R Sperr, Agnes Bretterklieber, et al.
Haematologica|October 26, 2014
Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control groupFriederike Braulke, Uwe Platzbecker, Catharina Müller-Thomas, et al.
Oncotarget|November 2, 2017
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditionsPeter Valent, Attilio Orazi, David P Steensma, et al.
Pageof 67

Showing results (591-600 of 662) with videos related to

Sort By:
Pageof 67
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2016
Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic MastocytosisCelalettin Ustun, Jason Gotlib, Uday Popat, et al.
Hemasphere|December 2, 2024
Dual specific STAT3/5 degraders effectively block acute myeloid leukemia and natural killer/T cell lymphomaDaniel Pölöske, Helena Sorger, Anna Schönbichler, et al.
The Journal of Allergy and Clinical Immunology|March 22, 2021
Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator ConferenceJason Gotlib, Tracy I George, Melody C Carter, et al.
Cell Reports. Medicine|March 18, 2026
Polθ activity modulates sensitivity to standard therapies in DNMT3A-deficient leukemiaBac Viet Le, Umeshkumar Vekariya, Monika M Toma, et al.
Wiener Klinische Wochenschrift|November 27, 2012
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectivesPeter Valent, Michel Arock, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 31, 2024
Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNMPeter Valent, Karin Hartmann, Gregor Hoermann, et al.
Haematologica|May 4, 2019
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditionsPeter Valent, Attilio Orazi, Michael R Savona, et al.
The Journal of Investigative Dermatology|February 13, 2021
Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on MastocytosisElisabeth Aberer, Wolfgang R Sperr, Agnes Bretterklieber, et al.
Haematologica|October 26, 2014
Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control groupFriederike Braulke, Uwe Platzbecker, Catharina Müller-Thomas, et al.
Oncotarget|November 2, 2017
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditionsPeter Valent, Attilio Orazi, David P Steensma, et al.
Pageof 67